Hope for Richard Scolyer eight months into risky brain cancer treatment
Australian Story Video / By Erin Semmler Posted Mon 22 Jan 2024 at 6:07pm
https://www.abc.net.au/news/2024-01-22/richard-scolyer-eight-month-scan-clear-australian-story/103375166
Watch Patient Zero video - Prof Richard Scolyer scans shows no recurrence of the Glioblastoma Cancer after 6 months from receiving his personalized immunotherapy by IV shortly before receiving the standard of care treatment.for stage 4 Glioblastoma. His treatment continues, with the next brain scan due within three months.
Leslie Chong supervised a Glioblastoma trial with Genentech, Paul Hopper and Leslie Chong lisenced the Paxalisib chemotherapy drug from Genentech in 2015, then on licenced the drug.
IMO, Leslie would be the Glioblastoma cancer expert within Imugene and would be all over the progress of Prof Scolver.and maybe already has contacted Prof Georgina Long.
Regards.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-11520
-
- There are more pages in this discussion • 4,216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.8¢ | 4.9¢ | 4.8¢ | $170.5K | 3.502M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 39318 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 4896118 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 151414 | 0.049 |
53 | 5325664 | 0.048 |
44 | 4815772 | 0.047 |
44 | 2994131 | 0.046 |
59 | 6070008 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 4751822 | 25 |
0.051 | 6255409 | 16 |
0.052 | 2579418 | 10 |
0.053 | 1653210 | 10 |
0.054 | 1596999 | 6 |
Last trade - 10.48am 07/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
IMU (ASX) Chart |